Kinetics of spontaneous filament nucleation via oligomers: insights from
  theory and simulation by Šarić, Anđela et al.
Kinetics of spontaneous filament nucleation via oligomers: insights
from theory and simulation
Anđela Šarića,1, 2, ∗ Thomas C. T. Michaelsa,2, 3, † Alessio
Zaccone,4 Tuomas P. J. Knowles,2 and Daan Frenkel2
1Department of Physics and Astronomy,
Institute for the Physics of Living Systems,
University College London, Gower Street, London, WC1E 6BT, U. K.
2Department of Chemistry, University of Cambridge,
Lensfield Road, Cambridge, CB2 1EW, U.K.
3Paulson School of Engineering and Applied Sciences,
Harvard University, Cambridge, MA 02138, USA.
4Department of Chemical Engineering, University of Cambridge,
Pembroke St, Cambridge CB2 3RA, U.K.
1
ar
X
iv
:1
61
0.
02
32
0v
2 
 [c
on
d-
ma
t.s
of
t] 
 4 
Ja
n 2
01
7
Abstract
Nucleation processes are at the heart of a large number of phenomena, from cloud formation to
protein crystallization. A recently emerging area where nucleation is highly relevant is the initiation
of filamentous protein self-assembly, a process that has broad implications in many research areas
ranging from medicine to nanotechnology. As such, spontaneous nucleation of protein fibrils has
received much attention in recent years with many theoretical and experimental studies focussing
on the underlying physical principles. In this paper we make a step forward in this direction
and explore the early time behaviour of filamentous protein growth in the context of nucleation
theory. We first provide an overview of the thermodynamics and kinetics of spontaneous nucleation
of protein filaments in the presence of one relevant degree of freedom, namely the cluster size.
In this case, we review how key kinetic observables, such as the reaction order of spontaneous
nucleation, are directly related to the physical size of the critical nucleus. We then focus on the
increasingly prominent case of filament nucleation that includes a conformational conversion of the
nucleating building-block as an additional slow step in the nucleation process. Using computer
simulations, we study the concentration dependence of the nucleation rate. We find that, under
these circumstances, the reaction order of spontaneous nucleation with respect to the free monomer
does no longer relate to the overall physical size of the nucleating aggregate but rather to the
portion of the aggregate that actively participates in the conformational conversion. Our results
thus provide a novel interpretation of the common kinetic descriptors of protein filament formation,
including the reaction order of the nucleation step or the scaling exponent of lag times, and put
into perspective current theoretical descriptions of protein aggregation.
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I. INTRODUCTION
Nucleation is the initial step in the formation of a new ordered structure through self-
organization. It is characterized by the presence of a free energy barrier to form the smallest
growth-competent unit of the new structure. Many phenomena in nature, science and en-
gineering are nucleated processes, including everyday examples such as cloud formation,
ice crystallization, the boiling of water, or the formation of bubbles in a champagne glass.
A particularly intriguing example of a nucleated process is the formation of protein fila-
ments, which is the topic of the present paper. This is a fundamental form of biological
self-assembly with important implications in areas ranging from medicine to materials sci-
ence. Biofilaments of actin and tubulin for instance underlie key events in cellular life, such
as providing the rigidity of the cellular cytoskeleton or participating in cell motility and cell
division.1–7 On the other side, aberrant filamentous protein aggregation is associated with
over 50 increasingly prevalent human disorders, such as Alzheimer’s, Parkinson’s diseases
and type II diabetes.8–14 These pathologies are intimately associated with the formation and
deposition in the brain or other organs of fibrillar protein aggregates, commonly known as
amyloids, which are the result of the aggregation of normally soluble and functional proteins
into elongated fibrillar structures characterized by their β-sheet rich structure. Amyloids,
however, are not only associated with disease, as it was initially believed, but have been
increasingly found to serve also many functional roles within living organisms15 and this
natural use of the amyloid state of proteins and peptides for functional purposes has inspired
many applications of these structures as materials for nanotechnology.16–20 The formation
of protein filaments has been established to be a nucleated polymerization process where a
slow spontaneous fibril nucleation step, also referred to as primary nucleation, is followed by
rapid growth through filament elongation6,21–41 and, in certain cases, self-replication through
secondary pathways.23,36,42–45 Here, the term “spontaneous” refers to the fact that the ran-
dom formation of the smallest growth-competent aggregates (nuclei) occurs directly from
solution, without the participation of surfaces or nucleation seeds. A particularly useful
approach to understand the way in which soluble proteins are converted into their fibrillar
counterparts through spontaneous nucleation is represented by kinetic models of filamentous
growth6,41,43,46–48. These kinetic models allow the underlying molecular-level mechanisms of
fibril formation to be connected with in vitro experimental measurements of the aggregate
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mass concentration e.g. by fluorescence microscopy or related techniques.49 In these models,
the spontaneous fibril nucleation step is commonly described as an nc-th order reaction with
respect to the free monomer concentration c with rate
r = knc
nc , (1)
where kn is the rate constant for spontaneous nucleation and nc is an effective reaction
order of spontaneous nucleation. Because nucleation is slow compared to growth, the
value of nc can be obtained experimentally from the concentration dependence of the half-
polymerization time t1/2 (defined as the time at which half of the monomers mass is se-
questered in aggregates), as the slope of this relationship in a double logarithmic plot gives
the so called scaling exponent γ defined by:
t1/2 = A c
γ, γ = −nc/2. (2)
A key question, in the field, is how to relate these experimentally measured kinetic de-
scriptors, including the reaction order nc and the scaling exponent γ, with the microscopic
characteristics of the underlying nucleation step, such as the physical size of the nucleating
aggregates. This connection provides important insights into the nature of the nucleation
process from experimental measurements. This problem has already received significant at-
tention in the protein aggregation literature, and we start here by providing a brief overview
of the simplest case of fibril nucleation by direct polymerization of monomers, incorporating
the published theories and quantitative experiments.
We then make a step forward and consider the increasingly evident process of protein
nucleation which includes a conformational change of the nucleating protein, giving rise to
multi-step nucleation processes via small oligomers. We study the kinetics of such a process
using coarse-grained computer simulations, and provide a novel physical interpretation of
the related kinetic parameters that are commonly measured in experiments. In particular,
we investigate the physical interpretation of the reaction order nc when proteins undergo a
conformational change during nucleation, and find that nc is determined by the portion of
the oligomer size that directly participates in the conformational conversion step.
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II. KINETICS OF SPONTANEOUS FIBRIL NUCLEATION WITH ONE DEGREE
OF FREEDOM
We start our discussion by reviewing the simplest model of fibril nucleation, in which
aggregates of different sizes but same structure are formed by direct polymerization of protein
monomers (Fig. 1(a)). We demonstrate that this model gives rise to spontaneous nucleation
if the cluster free energy function has a maximum as a function of cluster size. Under
these circumstances, it is found that, independently of the specific form of the cluster free
energy function, the reaction order of spontaneous nucleation nc is linked to the number of
monomers that compose the fibril nucleus.50 The simplicity of this model arises from the fact
that the aggregate size is the only degree of freedom in the system; in Section III we relax
this assumption by considering the effect of other potentially important degrees of freedom,
such as the internal structure of clusters.
A. Direct polymerization models of spontaneous fibril nucleation and the nucle-
ation theorem
To see how spontaneous nucleation emerges from a direct polymerization model, we con-
sider the following master equation describing the time evolution of the concentration f(t, N)
of aggregates of N monomers under the action of elongation and dissociation processes:51–55
∂f(t, N)
∂t
= c kon(N − 1)f(t, N − 1)− c kon(N)f(t, N) (3)
+ koff(N + 1)f(t, N + 1)− koff(N)f(t, N),
where c is the free monomer concentration, kon(N) and koff(N) are the (size-dependent)
rate constants for the addition and removal of monomers. These rate constants are linked
together by the detailed balance condition
c kon(N − 1)feq(N − 1) = koff(N)feq(N) (4)
where feq(N) is the cluster size distribution function at equilibrium. As detailed in Refs.54,55,
Eqs. (3) can be mapped onto a one-dimensional diffusion equation in a potential landscape
by assuming that f(t, N) varies sufficiently smoothly with N so that the continuum limit
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approximation applies:
∂f(t, N)
∂t
= konc
∂
∂N
[
∂f(t, N)
∂N
+ β
∂Φ(N)
∂N
f(t, N)
]
, (5)
where β = 1/(kT ) denotes the inverse temperature (k is the Boltzmann constant) and we
have introduced the cluster free energy function Φ(N) defined by the relationship
feq(N)
c
= e−βΦ(N). (6)
If the free energy function Φ(N) has a maximum at some value N∗, corresponding to the
critical nucleus size, then an expression for the rate of nucleation can be obtained from
Eq. (5) using the saddle point approximation:54–56
r ∼ konc
(
Φ′′(N∗)
2piβ−1
)
e−βΦ(N
∗). (7)
Thus, the master equation (3) of direct polymerization yields spontaneous nucleation. An
important point to recognize here is that Eq. (7) is valid for arbitrary cluster free energy
functions, so that depending on the specific form of Φ(N) several models of spontaneous
nucleation can be formulated. Classical nucleation theory,57,58 for instance, describes clusters
of dimensionality d as an object with associated volume and surface energy terms:
Φ(N) = aσN
d−1
d −N∆µ, (d > 1) (8)
where ∆µ = β−1 log(c/cs) is the supersaturation, cs the saturation concentration, σ the
surface tension (energy per unit surface) of the interface between the aggregate and the
surrounding solvent and a is a geometrical prefactor. The balance between unfavourable
entropy contribution from the loss of molecular degrees of freedom and the favourable energy
from the bonds between monomers creates a barrier. As N increases, more bonds are created
between monomers eventually overcoming the unfavourable entropy contributions that make
small cluster unstable. The nucleus formation is the rate limiting step and corresponds to
the point at which the free energy Φ(N) peaks (Fig.1(b)), and according to Eq. (7) the rate
of nucleation is given by:
r ∼ c e−β∆µN
∗
d−1 , N∗ =
(
(d− 1)aσ
d ∆µ
)d
. (9)
It is easy to verify from Eq. (9) that the nucleus size N∗ satisfies the relationship:
N∗ =
d log(r)
d log(c)
− 1 = nc − 1, (10)
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where the factor −1 comes from the concentration dependence of the prefactor in Eq. (7).
Equation (10) is a key result: it states that the nucleus size can be obtained from the slope
of a double logarithmic plot of the nucleation rate r against the monomer concentration c
and provides a direct relationship linking the physical size of nuclei to the experimentally
accessible reaction order nc of spontaneous nucleation. Importantly, Eq. (10), which was
derived here for the specific cluster free energy function of Eq. (8), turns out to be a far
more general result known as the nucleation theorem.50 This theorem states that Eq. (10) is
valid for arbitrary cluster free energy functions of the form Φ(N) = F (N)−N∆µ, so that
in a nucleating system where the aggregate number is the only relevant degree of freedom,
the experimental kinetic parameters nc and γ can always be linked directly to the physical
size of the nuclei. As a final note, we remind here that, in the context of classical nucleation
theory, the surface energy term F (N) of one dimensional clusters (d = 1) is independent of
N so that the cluster free energy function Φ(N) has no maximum (Fig. 1(b)). Hence, direct
polymerization in 1D is a downhill process, where every aggregate is more stable that the
previous ones; there is no classical nucleation in a truly 1D system.58
Direct polymerization models have been used widely in the protein aggregation literature
to describe spontaneous fibril nucleation. Important examples include classical nucleation
theory descriptions of amyloid as elongated 2D crystals.59–61 By considering prismatic ag-
gregates of fixed width but variable length and thickness build up by successively layered
β-sheets, expressions for the nucleation rate, nucleus size and nucleation work have been
obtained. In accordance with the nucleation theorem Eq. (10), these theories predict the
existence of a well-defined nucleus size which can be obtained from a log-log plot of the nu-
cleation rate against monomer concentration. Recent simulation and theoretical studies of
fibril nucleation have highlighted that introducing an interaction anisotropy in these models
results in a non-standard nucleation mechanism where the concept of a well-defined nucleus
size breaks and nuclei with varying size are observed instead.62–64
B. Pre-equilibrium kinetic models of spontaneous fibril nucleation
Worth mentioning at this point are pre-equilibrium kinetic models of fibril nucleation,
which often correspond to direct polymerization mechanisms. These models are character-
ized by two main assumptions. The first assumption is that clusters do not possess internal
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FIG. 1. (a) One-step nucleation is characterised by a single slow coordinate that corresponds to
the cluster size N . (b) Cluster free energy of classical nucleation theory for a 3D spherical cluster
and for a 1D cluster. Note that in 1D there is no free energy barrier. (c) Multistep nucleation
is characterised by additional slow coordinates. In the example shown here, the additional slow
coordinate corresponds to a structural change. The dashed line indicates a possible nucleation
pathway.
structure, so that the nucleus can be considered as a small piece of a long aggregate and the
cluster size is the only relevant degree of freedom in the system. The second assumption is
that the nuclei are in equilibrium with the soluble monomer, so that their concentration can
be obtained by equating the respective chemical potentials and the original kinetic problem
is now transformed into an equilibrium one. In these models the rate of nucleation can be
summarized as:6,7,21–24,41,46,65–67
r = A cnc . (11)
The exact connection between the exponent nc and the nucleus size is model dependent.
For example, some authors22–24,65,66 describe the rate of nucleation as the rate at which
nuclei elongate r = k+c [N∗], where k+ is the elongation rate constant and [N∗] is the
concentration of nuclei. The assumption that nuclei are in equilibrium with the monomers
results in [N∗] = KncN
∗ , where Kn is the equilibrium constant for the nucleus-monomer
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equilibrium. Combining these expressions yields r = k+KncN
∗+1 and we find the following
relationship between the reaction order nc of spontaneous nucleation and N∗50
N∗ =
d log(r)
d log(c)
− 1 = nc − 1. (12)
Other authors have employed similar pre-equilibrium arguments to obtain alternative expres-
sions for the nucleation rate that differ in the interpretation of the reaction order, including
N∗ = nc + 1 or N∗ = nc, but not in substance6,7,21,41,46,67. In all these models, in fact,
the value of the nucleus size is directly related to the slope of a plot of log(r) against the
logarithm of the monomer concentration, and thus the physical size of nuclei can in principle
be accessed from kinetic measurements. Several variations of these pre-equilibrium models
of nucleation have also been formulated, for instance by considering different addition rates
for monomer above and below N∗,24,65,68–70 by assuming that the nucleus is formed through
successive associations of small oligomers71–74 or by including reversible association steps for
aggregate sizes below N∗ and considering only irreversible polymerization for N > N∗.71–73,75
III. KINETICS OF SPONTANEOUS FIBRIL NUCLEATION WITH MULTIPLE
DEGREES OF FREEDOM
So far, we have considered the situation when the relevant degree of freedom of the nu-
cleating system is the physical size of aggregates. Under these circumstances, the nucleation
theorem50 provides a direct relationship between the nucleus size and the concentration
dependence of the nucleation rate. This result offers a powerful strategy for accessing key
information about the underlying nucleation step from experimental measurements of aggre-
gation kinetics. We now make a step forward and consider the more complicated situation
when the nucleation process is controlled by additional relevant degrees of freedom, such as
the internal structure of clusters. A prominent example of such a situation is realized when
the aggregating species change their shape or conformation during nucleation. In fact, when
considering the assembly of soft species, such as proteins, one needs to take into account the
fact that the species within the final aggregate might be in a significantly different state from
their counterparts in solution76,77. This situation can be viewed as a nucleation process that
is governed by multiple degrees of freedom (e.g. molecular rearrangements), in addition to
the cluster size, as sketched in Fig. 1(c). An important realization of this scenario is the ag-
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gregation of amyloid fibrils, where proteins acquire a β-sheet conformation within the fibril,
which is typically very different from their native conformations in solution. A large number
of structurally unrelated proteins form this type of fibrils, hence amyloid fibril formation
is regularly accompanied by a marked change in protein conformation. As demonstrated
below, in this scenario we do not find a single-valued relationship between nucleus size N∗
and the reaction order nc, but rather find that for a given value of nc the overall size of the
nucleating oligomers can change. Interestingly, however, we find that a modified nucleation
theorem connects nc to the sub-oligomer size within which the conformational change takes
place.
A. Conformational change in amyloid nucleation
Amyloidogenic proteins can be characterised according to their propensity to change their
conformation and acquire the β-sheet prone structure78–81. This propensity for the β-sheet
controls the rate and pathways of amyloid fibril nucleation 82–88. For proteins with low β-
sheet propensity, the conformational change from the native into the β-sheet form is slow
and energetically unfavourable, and the fraction of proteins in the β-sheet conformation
can act as a second slow degree of freedom in amyloid fibril formation, in addition to the
aggregation number.
A number of experimental studies have investigated amyloid nucleation pathways and
reported the existence of non-β-sheet clusters during amyloid formation89–97, suggesting a
multi-step nucleation mechanisms, where fibril nucleation takes place via disordered pre-
fibrillar clusters.27,30,35,49,98,99 This nucleation scenario, also called a nucleated conforma-
tional conversion or a two-step nucleation, has also been in focus of several theoretical
studies82,83,86,100? –106.
B. Computer simulations of amyloid nucleation
As a quantitative understanding of aggregation processes with more than one slow de-
gree of freedom is still presently lacking, it is beneficial to obtain interpretation of its kinetic
descriptors. Coarse-grained computer simulations can be of great help in this case. Here,
we use coarse-grained Monte Carlo simulations to study the kinetics and thermodynamics
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of nucleation of amyloid-like fibrils, for proteins with a range of β-propensities, attempt-
ing to rationalise experimentally measurable kinetic parameters in terms of the underlying
microscopic steps. Amyloid fibril formation is known to involve pre-nucleation disordered
oligomers, which do not possess much β-sheet content typical for fibrils, hence the oligomer
aggregation number emerges as one slow degree of freedom, while the β-sheet content, typ-
ical for fibrils, emerges as the second one. Our model, although presented in the context
of amyloid nucleation, is generic and can be applied to formation of any protein filaments
which involves a conformational change.
We employ a minimal Monte Carlo computational model that reproduces fibril nucle-
ation, as described in our previous work45,104. Briefly, the model accounts for the fact that
amyloidogenic peptides and proteins exist in minimally two states: a state in solution (de-
noted “s”) that can form disordered oligomers, and a higher free-energy state that can form
the β-sheet enriched fibrils (denoted “β”)104,109. The “s” state is modelled as a hard sphe-
rocylinder with an attractive patch at the tip, which represents non-specific interprotein
interactions, and drives the formation of small disordered oligomers, as depicted in Fig. 2
(a) and (b). The strength of the attraction between two “s” proteins is characterised with a
parameter ss, set to ss = 5.5kT in this paper. The fibril forming configuration is described
as a hard spherocylinder with an attractive side patch, which captures the interactions be-
tween the β-sheet prone state, such as the hydrogen-bonding and hydrophobic interactions,
and leads to the fibrillar aggregates (Fig. 2 (a) and (b)). The magnitude of this attraction
is considerably stronger than that between proteins in the soluble state, with ββ = 30kT .
The “s” -“β” interaction was set to sβ = ss + 1kT , as in our previous work104. Throughout
the text k denotes Boltzmann’s constant and T the temperature.
We start our simulations with 600 proteins randomly distributed in a periodic cubic box,
with all proteins in the “s” state. A protein is randomly chosen to be swapped between
the “s” and “β” state with a probability Pswap. The “s” → “β” swap is thermodynamically
unfavourable, and is penalised with an excess chemical potential of ∆µsβ, to reflect the loss
of the conformational entropy of the β-hairpin compared to the form in solution. This value
of ∆µsβ quantifies the protein’s β-sheet propensity, and controls the additional slow degree
of freedom. The degree of oligomerisation of the proteins in the “s”-state can be controlled
via the protein concentration c, as probed in the text. 110
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FIG. 2. The Monte Carlo model. (a) The protein can switch between two states: the soluble state,
“s”, that is lower in energy, interacts weakly with its own kind, and forms disordered oligomers;
and the β-sheet prone state,“β”, which is higher in energy, but interacts stronger with its own type
than the soluble state, and forms fibrils. Attractive patches are coloured in blue and red for the
“s” and “β” state respectively. (b) Aggregates of the two possible states: disordered oligomer (left
panel) and fibril (right panel). (c) At low protein concentrations nucleation proceeds via oligomers.
Illustration of an oligomer of the size N = 6, where the nucleation takes place when two proteins
simultaneously convert into the β-prone state, which triggers the nucleus growth into a long fibril.
To obtain information about the kinetics of fibril nucleation, we use the mean first passage
time as the proxy for nucleation rate, and calculate the rate of primary nucleation as the
inverse of the average lag time for nucleation45. The lag time is defined as the number of
MC steps needed for the first oligomer containing at least two β-proteins to appear in the
simulation, since the appearance of such a nucleus always leads to further fibril growth in
our simulations. We however note that such an oligomer can contain any composition of
the proteins in the “s” state and can be of any overall size. The average lag time is then
calculated from at least 6 repetitions of the same system with different random seeds, and
is expressed in the units of 108 MC steps.
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C. Kinetics of amyloid nucleation computed in simulations
At low protein concentrations, which is the regime we focus on in this paper, nucleation
proceeds via oligomers, as depicted in Fig. 2(c). Starting from an equilibrated population of
soluble proteins and their oligomers, we have calculated the rate of fibril nucleation across
a wide range of protein concentrations, as shown in Fig. 3(a), for the case of a protein
with a low propensity for the β-state (∆µsβ = 20kT ) and the protein with a relatively high
β-propensity (∆µsβ = 10kT ). As expected, the rate of nucleation increases with increasing
protein concentration, and protein β-propensity. The scaling exponent, nc, which relates
the reaction order of the nucleation step with the monomer concentration is given by the
slope of the plot in Fig. 3(a), and is found to decrease with increasing β-propensity.
What is the physical interpretation of the scaling exponent nc? An obvious characteristic
of nc is that it decreases sharply in the vicinity of the critical micelle concentration (cmc).
The cmc is the concentration above which increasing the total protein concentration leaves
the concentration of monomers in solution unaffected, causing the weaker dependence of
nucleation the rate on the protein concentration observed above the cmc (Fig. 3(b)). Since
amyloidogenic proteins typically occur at low concentrations, as low as nanomolar, we focus
here on the meaning of the exponent at low concentrations, much before the cmc is reached.
In this concentration regime, the measured scaling exponent is nc ≈ 4.5 and γ ≈ 2, for the
protein with a low and high β-propensity respectively (Fig. 3(a)) .
In light of the various theories of nucleation discussed in the Section II, where the scaling
of the nucleation rate was found to be linked with the protein concentration raised to the
critical nucleus size (Eq.(10)), we studied the size (aggregation number) of the nucleating
oligomers, a parameter that can be accessed directly in our simulations. Over the concentra-
tion range studied here, the average aggregation number of the nucleating oligomer changes
between N∗ ≈ 2− 12 for the low β-propensity protein (red circles in Fig. 3(c)) and between
N∗ ≈ 2− 4 for the high β-propensity one (blue crosses in Fig. 3(d)). Clearly, the size of the
nucleating oligomer increases with the increase in the protein concentration, as predicted in
our previous analysis of free energy barriers for nucleation via small oligomers104. However,
the size of the nucleating oligomer does not correspond to the value of the reaction order, and
this discrepancy becomes more prominent for the protein with low β-propensity. Instead, we
find that the reaction order corresponds to the subset of proteins in the oligomer that directly
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participate in the conversion step, as shown by the black filled circles in Fig. 3(c) for the low
β-propensity protein, and the black squares in Fig. 3(d) for the high β-propensity protein.
This subset includes the converting protein, and the proteins that directly interacted with it
in the conversion step. Not unexpectedly, the conformational conversion ceases to be a slow
degree of freedom for the high β-propensity protein, and the situation where the reaction
order corresponds to the oligomer size, described by classical nucleation, is recovered.
At this point, it is worth noticing that in order to test for the presence of possible additional
time-scales involved in our results, we repeated the rate measurements for a larger value
of the “s” → “β” conversion attempt, Pswap = 1 in our MC scheme (data not shown). In
this case, the reaction was overall faster, but the scaling exponent and sizes of the nucle-
ating oligomers remained unchanged, as the free energy landscape of the system remained
unaltered.
D. Control of kinetics of amyloid nucleation
In what follows, we explore the factors that control the kinetics of amyloid nucleation, or
in general, nucleation via oligomers which includes a conformational change of the nucleating
molecule. As previously discussed104, the free energy barrier for nucleation with such two
slow degrees of freedom is a trade-off between two opposing effects. At constant protein
concentration, the probability of protein conversion from a soluble into the β-sheet prone
state increases with the increase in the cluster size N . At the same time, the probability of
formation of an oligomer of the size N , given by c(N), decreases with N . Hence, it follows
that there is an intermediate cluster size that is optimal for nucleation at constant protein
concentration, and this optimal cluster size increases with increasing protein concentration.
In our simulations we can measure the conversion probability of a protein within an oligomer
of the given size per MC step,108 Pc(N), as shown in Fig. 4(a). We can also separately
measure the steady-state concentration of oligomers at a certain protein concentration, c(N),
from simulations under the situation when proteins are not allowed to convert into the β-
prone state, as shown in Fig. 4(b).
Clearly, the conversion probability initially increases with increasing oligomer size (Fig.
4(a)). The reason for this observation is two-fold: firstly, larger oligomers contain a larger
number of proteins available for conversion; secondly and more importantly, larger oligomers
14
(a) (b)
(c) (d)
FIG. 3. Kinetics of nucleation via oligomers from Monte Carlo simulations. (a) The rate of nu-
cleation versus protein concentration measured in simulations, for proteins with low propensity for
β-sheet (∆µsβ = 20kT , red circles), and high β-sheet propensity (∆µsβ = 10kT , blue crosses).
(b) The concentration of free monomers in solution versus the total protein concentration. The
solid line has the slope of 1, and the dashed line indicates the critical micelle concentrations. (c)
The average size of the overall nucleating oligomer (red circles) for the low β-propensity protein
(∆µsβ = 20kT from (a)), and the average size of the sub-oligomer participating in the conversion
step (black circles) . (d) The average sizes of the overall nucleating oligomer (blue crosses) and the
sub-oligomer participating in the conversion step (black squares) for the high β-propensity protein
(∆µsβ = 10kT from (a)).
can have more possible binding partners to energetically stabilise the unfavourable ‘s” →
“β” conversion. The slope of this function Pc(N) decreases abruptly at some point, after
which Pc(N) saturates to a plateau. On the other hand, the oligomer concentration c(N)
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decreases with increasing oligomer size (Fig. 4(b)). The probability of nucleation per MC
step of a cluster of size N should then be given by the product Pc(N) ·c(N). Fig. 4(c) shows
this product versus the oligomer size for five different protein concentrations. The nucleation
probability per MC step at a certain protein concentration, given by Pc(N) · c(N), clearly
exhibits a maximum, which corresponds to the most probable oligomer size for nucleation,
N∗. It essential to notice that this oligomer sizeN∗ does not correspond to the most probable
oligomer size observed in the system, which is N = 2 (Fig. 4(b)).
The overall rate of nucleation should then depend, up to the prefactor, on the product of
the two contributions, summed over all possible cluster sizes:
r ∼
∞∑
N=1
Pc(N) · c(N). (13)
Note that the physical dimensions or r are expressed in units of concentration per MC
step. Using Eq.(13), we calculated the rate of nucleation, r, for the protein with a low
β-propensity ∆µsβ = 20kT (Fig. 4(d)), and compared it to the corresponding nucleation
rate measured directly in simulations. The comparison shows an excellent agreement, up to
a prefactor, between the calculated rate and the rate measured in simulations, giving the
same scaling exponent. These results indicate that the reaction order is not only governed
by the size of the nucleating cluster, as it is in the case of classical nucleation, but also by
the probability of conformational conversion within such a cluster, which is an additional
slow degree of freedom in this nucleation process.
The probability for the conformational conversion is in general governed by the free energy
difference between the two conformational forms, given by ∆µsβ in our simulations, and the
interactions between the species within the oligomer, given by ss and sβ in our simula-
tions. To test the hypotheses that the scaling exponent is controlled by the functional form
of Pc(N), we computed the conversion probability per MC step Pc(N) for three proteins
with different β-propensities, while keeping the interaction parameters unchanged, as shown
in Fig. 5(a). Trivially, the conversion probability increases with increasing β-propensity.
However, the onset of the plateau occurs at smaller oligomer sizes for proteins with higher
β-propensities, as marked by arrows in Fig. 5(a). This saturation can be viewed as the
average number of neighbouring proteins needed for the conversion to become sufficiently
probable. This number is smaller for proteins with higher β-propensity, and will determine
the value of the reaction order. Fig. 5(b) shows the calculated nucleation rate, following
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(a) (b)
(c) (d)
FIG. 4. (a) The calculated probability of “s” → “β” conversion of a single protein within an oligomer
of the size N , for the protein with a low β-propensity, ∆µsβ = 20kT , per one MC step. (b) Steady-
state concentration of “s”-state oligomers of size N for five different protein concentrations. (c)
Product of a conversion probability within an oligomer of a size N per MC step, from (a), with
the concentration of the oligomers of size N , from (b). (d) The calculated rate: Sum of the
concentrations of all oligomers multiplied by the corresponding protein conversion rates within an
oligomer, across the concentration range, as in Eq.(13). The nucleation rate measured in simulations
for the same set of parameters is shown for comparison (red circles), taken from Fig.3(a).
Eq.(13), for the three proteins with different β-propensities. Indeed, a decrease in the β-
propensity leads to an increase in the reaction order. Hence the functional form of Pc(N)
has a profound effect onto the reaction order, where the latter can be interpreted as the
number of interacting proteins within the cluster necessary to stabilize the conformational
17
(a) (b)
FIG. 5. (a) The calculated probability of “s” → “β” conversion per MC step of a single protein within
an oligomer of the size N , for three different β-propensities, from top to bottom: ∆µsβ = 10kT ,
∆µsβ = 20kT , and ∆µsβ = 30kT . The arrows mark the respective saturation of the conversion
probability. (b) The calculated rate, from Eq.(13), for three different β-propensities.
conversion.
CONCLUSIONS
In this paper, we have studied the phenomenon of spontaneous nucleation in the context
of protein filament formation, a process which has been discussed in the literature for over
50 years and has important implications in many areas of research. We have considered the
phenomenon of spontaneous fibril formation first by assuming that the cluster size is the only
relevant degree of freedom in the system. In this situation, the nucleation theorem states
that the kinetic descriptors commonly measured in experiments, such as reaction orders and
scaling exponents, relate in a direct way with the critical nucleus sizeN∗.
We then introduced an additional slow coordinate in the nucleating system by allowing
for a conformation conversion of the aggregating proteins. Using coarse-grained Monte-Carlo
simulations, we probed the kinetics of this fibril nucleation process with two slow degrees of
freedom. In the case of amyloid nucleation, this includes the aggregation number and the
content of the fibrillar structure, the latter being characterised by the fraction of proteins
in a β-sheet conformation. Our analysis showed that, in this case, the reaction order nc
18
does not relate with the physical size of the aggregating oligomers, but that nc is modulated
by the structural conversion within oligomers as the additional slow structural variable is
describing the system. Under these circumstances, nc is found to correspond to the sub-
cluster size that directly participates in the conversion and stabilizes the converted protein.
These results provide direct practical insights into the interpretation of kinetic data of fibril
formation.
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